128940.KO Hanmi Pharm Co Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
465,000 KRW
Close of Nov 5, 2026
302,000 644,643
Market cap
KRW 5.90T
P/E
24.8x
P/B
3.73x
ROE
18.3%
Dividend yield
0.52%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 128940.KO undervalued?

Graham number
Price465,000
Graham value229,426
Premium102.7%

128940.KO trades 102.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hanmi Pharm Co Ltd fundamental analysis

No fundamental analysis for Hanmi Pharm Co Ltd yet.

Hanmi Pharm Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hanmi Pharm Co Ltd

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company's products include Gugutams, a urological combination therapy combining two active ingredients: tamsulosin, a treatment for Obstructive Prostatic Growth (OPG), a…

Full company profile